Alcoholic Liver Diseases Treatment Market
Alcoholic Liver Diseases Treatment Market Study by Alcoholic Fatty Liver Diseases, Alcoholic Liver Hepatitis, Liver Fibrosis, and Liver Cirrhosis for Pentoxifylline and Others From 2024 to 2034
Analysis of Alcoholic Liver Diseases Treatment Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Alcoholic Liver Diseases Treatment Market Outlook (2024 to 2034)
Expanding at a CAGR of 7.8%, the global alcoholic liver diseases treatment market is projected to increase from a valuation of US$ 2.29 billion in 2024 to US$ 4.84 billion by 2034.
Because alcohol consumption problems are becoming more common and several people are gaining consciousness about the catastrophic health consequences of alcoholic liver disease (ALD), there is an increasing need for ALD therapies worldwide.
This rise is because of the growing patient base as well as the advantages and broader uses of ALD therapies. New developments in ALD therapeutics have promise not just for liver function but also for metabolic illnesses, reducing inflammation, and general well-being.
As per alcoholic liver diseases treatment industry analysis, the market is growing because of the interest that different medical disciplines are showing in these expanding applications. Effective therapies are desperately needed because of the increased frequency of ALD, especially in potentially high growth countries where alcohol abuse and lifestyle changes are common.
This has sparked investigation into cutting-edge treatments, such as liver regeneration methods, anti-inflammatory drugs, and antioxidants. Healthcare practitioners are making efforts to increase public knowledge about ALD and its therapies. Physicians are using several strategies to inform the general public and people who are at risk.
Public health campaigns that draw attention to the dangers of excessive alcohol consumption, the inclusion of alcohol screening in regular physical examinations, teamwork with addiction specialists to provide all-encompassing care, the use of digital platforms for patient education and support, and outreach initiatives aimed at high-risk groups are some of these initiatives.
To keep medical professionals informed about the most recent possibilities for treating ALD, medical groups are holding conferences and seminars. Specialized liver clinics have been developed by certain hospitals, providing focused care, and increasing awareness of ALD therapies.
| Report Attribute | Detail |
|---|---|
| Alcoholic liver Diseases Treatment Market Size (2024E) | US$ 2.29 Billion |
| Forecasted Market Value (2034F) | US$ 4.84 Billion |
| Global Market Growth Rate (2024 to 2034) | 7.8% CAGR |
| Middle East & Africa Market Growth Rate (2024 to 2034) | 7.5% CAGR |
| Alcoholic Fatty Liver Diseases Segment Value (2034F) | US$ 2.08 Billion |
| North America Market Share (2024E) | 33.9% |
| East Asia Market Share (2034F) | 10.3% |
| Key Companies Profiled | Takeda Pharmaceutical Company Limited; Bristol-Myers Squibb Company; Merck & Co Inc.; Pfizer Inc.; Sanofi; Novartis; AbbVie Inc.; Gilead Sciences Inc. |
Alcoholic liver diseases are the result of overconsumption of alcohol, which damages the liver, leading to liver cirrhosis, inflammation, and liver scarring. Alcohol remains the most common cause of chronic diseases in the United States and other Western countries, as per the alcoholic liver diseases treatment industry analysis.
The liver is one of the vital organs of the body, which performs several functions, such as regulating cholesterol and blood sugar, filtering out blood toxins, and many others. The symptoms of alcoholic liver diseases generally develop in middle age between 30 to 40 years.
The range of clinical features of alcoholic liver diseases varies widely from asymptomatic to end-stage liver diseases. The major symptoms of alcoholic liver diseases are portal hypertension, jaundice, abdominal pain, diarrhea, and others. According to CDC (Centers for Disease Control and Prevention), the number of deaths from alcoholic liver diseases was 19,388 in the year 2014.
Alcoholic liver diseases are one of the main reasons for liver transplantation. There are four main stages of alcoholic liver diseases - alcoholic fatty liver disease, alcoholic liver hepatitis, liver fibrosis, and liver cirrhosis.
According to NHS (National Health Services), alcoholic liver diseases accounted for 82% of overall alcohol-specific deaths. Abstinence and lifestyle modifications, pharmacotherapy, nutritional supplements, and several other medications improve the survival rate in alcoholic cirrhotic patients.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Alcoholic Liver Diseases Treatment Market: Drivers and Restraints
Rapidly changing lifestyle pattern, such as increasing alcohol consumption and unhealthy diets are the factors driving the market, as per the alcoholic liver diseases treatment industry outlook. The increasing prevalence of liver diseases is also expected to boost the market during the stated forecast period.
Rising R&D funding by governments for the development of novel therapies to treat chronic liver diseases also escalates the market for alcoholic liver diseases treatment.
Fact.MR published alcoholic liver diseases treatment industry outlook states that the side effects associated with medications are hampering the growth of the market during the overall forecast period. Stringent government regulations for the approval of drugs also decline the market growth. Lack of awareness and poor diagnosis facilities in the low economic regions also degrade the market.
Alcoholic Liver Diseases Treatment Market: Overview
The global market is evaluated to witness high growth over the forecast period. Alcoholic liver diseases cause severe complications, as stated in the alcoholic liver diseases treatment industry analysis. Steroids and pharmacotherapies hold a noteworthy market share in the global market.
Nutritional supplements, such as betaine have shown to reduce disease severity. Alcohol consumption has become quite common, and the increasing prevalence of alcoholic liver diseases is expected to lead to the robust growth of the market.
Early detection reduces the progression of further liver damage. However, a majority of drugs are introduced in the generic form in market, and thus, there exists high competition among local and regional players.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Alcoholic Liver Diseases Treatment Market: Regional Outlook
Geographically, the global market is segmented into North America, Latin America, Europe, Asia Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). The North American market is expected to be the dominant revenue share, owing to the high prevalence of the alcoholic liver diseases, and an increase in the consumption of alcohol.
The European market is expected to have a significant share in the global industry throughout the forecast period, due to modern lifestyles. The market in Asia Pacific is also evaluated to grow at a significant rate, due to lifestyle changes and the lack of awareness among individuals.
The Middle East and African region shows moderate growth in the market, due to poor diagnosis facilities and lack of awareness among patients.
Alcoholic Liver Diseases Treatment Market: Key Players
Examples of some of the key players operating in the global alcoholic liver diseases treatment market are
- Johnson & Johnson Services Inc.
- Sanofi
- Upsher-Smith Laboratories LLC
- F. Hoffmann-La Roche AG
- Novartis AG
- GlaxoSmithKline plc
- Pfizer Inc.
- Bayer AG
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies Involved
- Technology
- Value Chain
Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Segmentation of the Alcoholic Liver Diseases Treatment Market Research
-
By Indication :
- Alcoholic Fatty Liver Diseases
- Alcoholic Liver Hepatitis
- Liver Fibrosis
- Liver Cirrhosis
-
By Treatment :
- Pentoxifylline
- Glucocorticosteroids
- Betaine
- Others
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
- Others
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Indication
- 6.2. Treatment
- 6.3. Distribution Channel
- 7. Global Market Analysis and Forecast, By Indication
- 7.1. Alcoholic Fatty Liver Disease
- 7.2. Alcoholic Liver Hepatitis
- 7.3. Liver Fibrosis
- 7.4. Liver Cirrhosis
- 8. Global Market Analysis and Forecast, By Treatment
- 8.1. Pentoxifylline
- 8.2. Glucocorticosteroids
- 8.3. Betaine
- 8.4. Others
- 9. Global Market Analysis and Forecast, By Distribution Channel
- 9.1. Hospital Pharmacies
- 9.2. Retail Pharmacies
- 9.3. Drug Stores
- 9.4. Online Pharmacies
- 9.5. Others
- 10. Global Market Analysis and Forecast, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Western Europe
- 10.4. Eastern Europe
- 10.5. East Asia
- 10.6. South Asia & Pacific
- 10.7. MEA
- 11. North America Sales Analysis and Forecast, by Key Segments and Countries
- 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 13. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 14. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 16. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 17. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 18. Sales Forecast by Indication, Treatment, and Distribution Channel for 30 Countries
- 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 20. Company Profile
- 20.1. Johnson & Johnson Services Inc.
- 20.2. Sanofi
- 20.3. Upsher-Smith Laboratories LLC
- 20.4. F. Hoffmann-La Roche AG
- 20.5. Novartis AG
- 20.6. GlaxoSmithKline plc
- 20.7. Pfizer Inc.
- 20.8. Bayer AG
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Indication
Table 3: Global Market US$ Mn Forecast by Treatment
Table 4: Global Market US$ Mn Forecast by Distribution Channel
Table 5: North America Market US$ Mn Forecast by Country
Table 6: North America Market US$ Mn Forecast by Indication
Table 7: North America Market US$ Mn Forecast by Treatment
Table 8: North America Market US$ Mn Forecast by Distribution Channel
Table 9: Latin America Market US$ Mn Forecast by Country
Table 10: Latin America Market US$ Mn Forecast by Indication
Table 11: Latin America Market US$ Mn Forecast by Treatment
Table 12: Latin America Market US$ Mn Forecast by Distribution Channel
Table 13: Western Europe Market US$ Mn Forecast by Country
Table 14: Western Europe Market US$ Mn Forecast by Indication
Table 15: Western Europe Market US$ Mn Forecast by Treatment
Table 16: Western Europe Market US$ Mn Forecast by Distribution Channel
Table 17: Eastern Europe Market US$ Mn Forecast by Country
Table 18: Eastern Europe Market US$ Mn Forecast by Indication
Table 19: Eastern Europe Market US$ Mn Forecast by Treatment
Table 20: Eastern Europe Market US$ Mn Forecast by Distribution Channel
Table 21: East Asia Market US$ Mn Forecast by Country
Table 22: East Asia Market US$ Mn Forecast by Indication
Table 23: East Asia Market US$ Mn Forecast by Treatment
Table 24: East Asia Market US$ Mn Forecast by Distribution Channel
Table 25: South Asia & Pacific Market US$ Mn Forecast by Country
Table 26: South Asia & Pacific Market US$ Mn Forecast by Indication
Table 27: South Asia & Pacific Market US$ Mn Forecast by Treatment
Table 28: South Asia & Pacific Market US$ Mn Forecast by Distribution Channel
Table 29: MEA Market US$ Mn Forecast by Country
Table 30: MEA Market US$ Mn Forecast by Indication
Table 31: MEA Market US$ Mn Forecast by Treatment
Table 32: MEA Market US$ Mn Forecast by Distribution Channel
Table 33: North America Market US$ Mn Forecast by Country
Table 34: North America Market US$ Mn Forecast by Indication
Table 35: North America Market US$ Mn Forecast by Treatment
Table 36: North America Market US$ Mn Forecast by Distribution Channel
Table 37: Latin America Market US$ Mn Forecast by Country
Table 38: Latin America Market US$ Mn Forecast by Indication
Table 39: Latin America Market US$ Mn Forecast by Treatment
Table 40: Latin America Market US$ Mn Forecast by Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 10: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 14: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment
Figure 15: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 17: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 18: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment
Figure 19: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 20: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 22: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment
Figure 23: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 24: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 25: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 26: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment
Figure 27: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 28: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 29: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 30: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment
Figure 31: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 32: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 33: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 34: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment
Figure 35: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 36: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 37: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 38: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment
Figure 39: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 40: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
Why is demand for alcoholic liver diseases treatment escalating?
Rapidly changing lifestyle patterns, such as increased alcohol consumption and unhealthy diets are boosting the demand.
What aspects hamper the demand growth for alcoholic liver diseases treatment?
The side effects associated with medications limit the demand for alcoholic liver diseases treatment.
Which region contributes the most to the global alcoholic liver diseases treatment market?
North America is projected to lead the global market going forward.
Alcoholic Liver Diseases Treatment Market